Mecuris GmbH, a Munich, Germany-based commercial-stage medical technology startup focusing on the digitalization of prosthetics and orthotics, completed its €3.6m Series A financing round.
Backers included Bayern Kapital and High-Tech Gründerfonds (HTGF), new investors Vesalius Biocapital, Mulcan International Investments and one of the Top 5 hospital chains in Germany.
The company intends to use the funds to penetrate the European market, increase sales and to continue to develop digital solutions to complement its portfolio.
Mecuris is a medical technology startup that specializes in providing orthopedic technicians with an online platform for customizable and 3D-printed orthotics and prosthetics – delivered within days. Orthoses and prostheses can be further styled individually (color, texture, ornaments, logos, etc.).
It is full CE-mark and ISO certificated.